As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: March 7, 2012
by 9 News
British scientists have discovered a type of antibody in mice that blocks a hallmark of Alzheimer’s disease, offering a potential new route to treatment, according to research published on Tuesday.
The antibodies shut down a protein called Dkk1 that in turn stops the formation of amyloid plaque in the brain, a key factor in the progression of Alzheimer’s, said the findings in the Journal of Neuroscience.
When this plaque builds up, it leads to a loss of connection between neurons, known as synapses, in the part of the brain known as the hippocampus which handles learning and memory.
“These novel findings raise the possibility that targeting this secreted Dkk1 protein could offer an effective treatment to protect synapses against the toxic effect of amyloid-B,” said lead author Patricia Salinas of the University College London Department of Cell and Developmental Biology.
“Importantly, these results raise the hope for a treatment and perhaps the prevention of cognitive decline early in Alzheimer’s disease.”
The research has only been done in mice and more work is needed to see if it would be relevant in humans.
Previous research has shown that the autopsied brains of people with Alzheimer’s disease have higher levels of Dkk1 than normal brains, but scientists were unsure why.
The latest study on mice showed that animals exposed to antibodies against Dkk1 had more of their synapses survive than other Alzheimer’s mice that were not given the treatment.
The research was funded by Alzheimer’s Research UK and the Biotechnology and Biological Sciences Research Council.
There is no cure for Alzheimer’s, a progressive brain disease which along with other forms of dementia affects more than 35 million people worldwide.
Alzheimer’s disease (AD) is a progressive brain disease and the 6th leading cause of death in the U.S. While symptoms of AD such as memory loss and impaired judgement are widely recognized, we know less...
Autoimmune diseases, such as multiple sclerosis and coeliac disease, may be linked to a heightened risk of dementia, indicates a large long term study published in the Journal of Epidemiology & Community Health March 1, 2017. Researchers...
You are what you eat; but more than than, your brain is very much what you eat, at least according to mounting evidence from scientists. A new collection of five studies published by Clinical Psychological...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.